Xiao Zhou None;
Qinqin Zhang Carl Zeiss Meditec, Code E (Employment);
Zahra Nafar Carl Zeiss Meditec, Code E (Employment);
Sujata Rijal None;
Mengxi Shen None;
Kasra Rezaei None;
Giovanni Gregori Carl Zeiss Meditec, Code F (Financial Support);
Philip Rosenfeld Annexon, Apellis, Bayer, Boehringer-Ingelheim, Carl Zeiss Meditec, Chengdu Kanghong Biotech, InflammX, Ocudyne, Regeneron, Unity Biotechnology, Code C (Consultant/Contractor), Alexion, Carl Zeiss Meditec, Gyroscope Therapeutics, Stealth BioTherapeutics, Code F (Financial Support), Apellis, Ocudyne, Valitor, Verana Health, Code I (Personal Financial Interest);
Amir Kashani Carl Zeiss Meditec, Code C (Consultant/Contractor), Carl Zeiss Meditec, Code F (Financial Support), Carl Zeiss Meditec, Code R (Recipient);
Ruikang Wang Carl Zeiss Meditec, Code C (Consultant/Contractor), Carl Zeiss Meditec, Colgate Palmolive Company, Estee Lauder Inc, Code F (Financial Support), US8,750,586, US8,180,134, US9,282,905, US9,759,544, US 10,354,378, US10,529,061., Code P (Patent)